AUG 21, 2020 1:55 PM PDT

Investigating Cancer's Metabolism for a New Drug Target

WRITTEN BY: Jasper Cantrell

Cancer cells are quite similar to normal cells in many ways, but it’s the small differences that really matter. One of these slight differences is in their metabolism.

Normally, cells use aerobic respiration, aka oxygen-based energy production, to metabolize sugar into energy. This method produces a large amount of energy but requires an abundance of oxygen and other nutrients. Cancer cells use something called glycolysis, which is far less efficient but requires fewer nutrients and no oxygen. This shift from one energy production to another is called the Warburg Effect, and it allows cancer cells to grow quickly with low upkeep.

A team from the University Children’s Hospital in Heidelberg, Germany, thought this metabolic shift could be a good target for new cancer drugs. They hypothesized that the protein ADP-dependent glucokinase (ADPGK), a sort of nutrient sensor involved with controlling the Warburg effect, might be a critical junction for cancer malignancy.

This new study would watch markers of metabolism shift of the Burkitt Lymphoma cells after activation with a synthetic signal. Activation would induce rapid growth in the cancer cells. The team would knock out the ADPGK gene (essentially delete it from the genome), and in theory, the cells would not experience the same explosive growth. This would confirm that ADPGK plays a critical roll in the metabolism of cancer cells.

The study found that ADPGK knockouts inhibited the activation of the Burkitt’s Lymphoma cells in the lab. There was a decrease in cellular growth markers and an increase in apoptosis markers (a programmed cell death pathway). Further analysis led the team to believe this suppression was due to the cancer cells being unable to obtain glucose, an essential fuel in glycolysis and aerobic metabolisms.

The discovery of the critical junction in Burkitt’s Lymphoma metabolism is quite a find. It offers a new source of drug targets for therapy studies and provides us with a better understanding of cancer metabolism in the body.

The study ends, “…we have thus uncovered a novel target in the form of ADPGK on the cross-roads of these pathways, and its targeting via development of novel therapeutics could prove to be indispensable for curbing aggressively growing malignancies.”

Sources: Nature Scientific Reports, National Cancer Institute, Nature Video

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
AUG 19, 2020
Immunology
Cancer Mutation Improves Chemo Drug Performance
AUG 19, 2020
Cancer Mutation Improves Chemo Drug Performance
When it comes to cancer biomarkers, it’s often the genetic signatures that are associated with poor patient outcom ...
AUG 31, 2020
Cancer
Targeting Your Inner Hedgehog to Fight Chemoresistance in Colorectal Cancer
AUG 31, 2020
Targeting Your Inner Hedgehog to Fight Chemoresistance in Colorectal Cancer
Chemoresistance is a serious problem for many cancer therapies. Solutions to this problem are harder to come by than the ...
SEP 06, 2020
Cancer
Focal HIFU ablation improves prostate cancer patients' quality of life
SEP 06, 2020
Focal HIFU ablation improves prostate cancer patients' quality of life
Research published in The Journal of Urology offers an alternative to invasive prostate cancer treatments like surg ...
SEP 10, 2020
Cancer
Pancreatic cancer patients see hope in this newly developed drug
SEP 10, 2020
Pancreatic cancer patients see hope in this newly developed drug
A new drug developed by researchers at the University of Sheffield hopes to improve life expectancy and quality of life ...
OCT 04, 2020
Cancer
Mutations form in specific genomic patterns based on external and internal factors
OCT 04, 2020
Mutations form in specific genomic patterns based on external and internal factors
New research published in Nature Genetics provides insight on the formation of mutations in the genome. Researchers from ...
OCT 12, 2020
Drug Discovery & Development
Researchers Solve Key Problem for Cancer Immunotherapy
OCT 12, 2020
Researchers Solve Key Problem for Cancer Immunotherapy
Cancer immunotherapies are becoming increasingly promising as a standard-of-care treatment. However, despite their promi ...
Loading Comments...